In a partnership primed for flavor-forward content and one-of-a-kind recipe inspiration, the McCormick (R) brand announces a two-year long collab with lifestyle icon, Paris Hilton and her next-gen ...
In a partnership primed for flavor-forward content and one-of-a-kind recipe inspiration, the McCormick® brand announces a two ...
Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare ...
SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: ...
$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic ...
16h
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors Presented ...
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...
After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...
NEMLUVIO is the first authorized monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling ...
Frost & Sullivan is pleased to announce that Aeronero has been recognized with the 2025 Global Transformational Innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback